PD-066 Does reporting expected duration and severity of...

Lung Cancer 2005 / 7 Vol. 49

PD-066 Does reporting expected duration and severity of adverseevents provide clinically relevant information when selecting a chemotherapy regimen? An example using pemetrexed and docetaxel

Bhalla, S., Thatcher, N., Reck, M., Tilden, D., Gatzemeier, U., Stynes, G., Leschinger, M., Fitzgerald, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80399-x
Date:
July, 2005
File:
PDF, 287 KB
english, 2005
Conversion to is in progress
Conversion to is failed